Padma Shri for Hemophilia and Oncology Pioneers Signals Healthcare Progress

In a ceremony scheduled for 25 May at Rashtrapati Bhavan, President Droupadi Murmu will confer the prestigious Padma Shri upon two physicians whose careers have redefined treatment standards for hemophilia and cancer. Dr. Suresh Hangalwadi’s decades-long focus on affordable hemophilia management has helped countless children avoid permanent disability, while Dr. P. Vijay Anand Reddy’s leadership in oncology has expanded access to advanced therapies across Telangana and beyond. Speaking exclusively, Dr. Hangalwadi stressed that early intervention through prophylaxis can dramatically alter life trajectories for patients whose families often face catastrophic costs. He called on authorities to ensure school attendance support and workplace reservations for affected youth under existing disability legislation. Dr. Reddy accepted the award on behalf of every patient, colleague, and teacher who shaped his journey, framing the recognition as validation of collaborative efforts in oncology research and patient advocacy. Together, their stories illustrate how targeted medical excellence can drive systemic change and inspire future generations of specialists committed to equitable healthcare delivery.